StockData
Actinium Pharmaceuticals, Inc. logo

Actinium Pharmaceuticals, Inc. (ATNM) stock

ATNMNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/3084% below fair value
$1.05−0.02 (-1.87%)

Close on Nov 20, 2026Market cap $33.01MP/E 2.9Yield –

Actinium Pharmaceuticals gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2021 it was $244.00K.

Annual gross profit

PeriodPeriod endValueChange
FY2021Dec 31, 2021$244.00K–
FY2011Dec 31, 2011$0–
FY2010Dec 31, 2010$0–

More Actinium Pharmaceuticals figures

See a number that looks wrong?